Home > Drug Search >
  • company_query: AtheroNova
  •   > 
Drug Filter
Category:
chemistry (21) biology (4)
Status:
Approved (1) Phase Ⅲ (1) Phase Ⅱ (13) Phase Ⅰ (9)
Clinical Stage:
Pending (5) Active (10) Discontinued (9)
Bio-Type:
Cell therapy (1) Vaccine (1) Whole antibody (1)
Indication:
Anaesthetic (1) Arthritis (1) Asthma (1) Atherosclerosis (1) Atrial fibrillation (1) Diabetic nephropathy (1) Rheumatic disorders (1) Gastric cancer (1) Heart failure (1) Ischaemia (1) Influenza virus infection (1) Melanoma (1) Multiple sclerosis (MS) (2) Myocardial infarction (MI) (1) Neuropathic pain (1) Ovarian cancer (1) Peptic ulcer (1) Prostate cancer (1) Rheumatoid arthritis (RA) (2) Type 2 diabetes (1) Cardiogenic shock (1) Low back pain (1) Stroke (2) Bipolar disorder (1) Rejection in heart transplantation (1) Renal carcinoma (1) Hypertrophic cardiomyopathy (1) Gout (1) Gingival diseases (1) Mesothelioma (1) Musculoskeletal pain (1) Central nervous system disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top